STR 241220 17.50C (STR241220C17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

STR241220C17500

Watchlist

3.98
0.000.00%

15min DelayClose Nov 21 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Piper Sandler Maintains Overweight on Sitio Royalties, Raises Price Target to $28
BenzingaNov 18 12:14 ET · Ratings
Sitio Royalties Analyst Ratings
BenzingaNov 18 12:12 ET · Ratings
Here's Why We're Wary Of Buying Sitio Royalties' (NYSE:STR) For Its Upcoming Dividend
Simply Wall StNov 14 08:36 ET
Truist Financial Maintains Sitio Royalties(STR.US) With Buy Rating, Announces Target Price $29
Moomoo NewsNov 11 07:31 ET · Ratings
Sitio Royalties (NYSE:STR) Will Pay A Smaller Dividend Than Last Year
Yahoo FinanceNov 10 07:05 ET
Sitio Royalties Boosts 2024 Outlook With Strong Q3 Results
TipRanksNov 8 00:23 ET

Comments

Moomoo AI

Jan 19 04:40

Sitio Royalties' future revenue growth is expected to outperform the industry, boosting its P/S ratio. Shareholders' confidence in future revenues supports this ratio, making a significant share price drop unlikely soon.

Market Participants Recognise Sitio Royalties Corp.'s (NYSE:STR) Revenues

Moomoo AI

Dec 10, 2023 07:13

While Sitio Royalties' return on equity and stock price might fell short, its net income growth, efficient reinvestment, and recent initiation of dividends are seen as positives. Analysts predict an increase in the company's earnings.

Should Weakness in Sitio Royalties Corp.'s (NYSE:STR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Analysts Notebook

Jul 11, 2022 07:23

Columns Top upgrades and downgrades on 7/11: MRVL, AFRM, LULU, BAC and more

Upgrades
• $APi Group (APG.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $23
• $Axos Financial (AX.US)$ : KBW Upgrades to Outperform from Marketperform - PT $56 (from $52)
• $Bank of America (BAC.US)$: Societe Generale Upgrades to Buy from Hold - PT $37.50 (from $40.50)
• $Element Solutions (ESI.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $22 (from $24)
• $Fate Therapeutics (FATE.US)$ : BMO Capital Upgrades...

Analysts Notebook

Jul 8, 2022 06:47

Columns Top upgrades and downgrades on 7/8: PYPL, UPST, AAL, RCKT and more

Upgrades
• $Vita Coco (COCO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12 (from $10)
• $Diebold Nixdorf (DBD.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $5
• $Eversource Energy (ES.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $97 (from $92)
• $Howmet Aerospace (HWM.US)$ : Benchmark Upgrades to Buy from Neutral - PT $40
• $The Interpublic Group of Companies (IPG.US)$ : Wells Fargo Upgrades to Overweight...

Analysts Notebook

Jul 1, 2022 06:54

Columns Top upgrades and downgrades on 7/1: CMCSA, FDX, XPEV, HOG and more

Upgrades
• $Coupang (CPNG.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $28)
• $First Republic Bank (FRC.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $188 (from $210)
• $Sitio Royalties (STR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $43 (from $36)
Downgrades
• $Duck Creek Technologies (DCT.US)$ : JMP Securities Downgrades to Market Perform from Market Outperform
•...